Consolidated balance sheet
in CHF 1,000 | Note | 30.06.2023 | 31.12.2022 | Variance | Variance |
|---|---|---|---|---|---|
|
|
|
| absolute | in % |
Cash and cash equivalents |
| 2,172,146 | 2,208,733 | –36,587 | –1.7 |
Receivables arising from money market papers |
| 163,809 | 196,993 | –33,184 | –16.8 |
Due from banks |
| 1,770,479 | 1,539,929 | 230,550 | 15.0 |
Due from customers |
| 5,446,414 | 5,758,911 | –312,497 | –5.4 |
Trading portfolios |
| 290 | 172 | 118 | 68.6 |
Derivative financial instruments |
| 84,253 | 58,540 | 25,713 | 43.9 |
Financial instruments at fair value | 184,376 | 180,013 | 4,363 | 2.4 | |
Financial instruments measured at amortised cost | 2,509,725 | 2,436,650 | 73,075 | 3.0 | |
Joint venture companies |
| 24 | 24 | 0 | 0.0 |
Property and equipment | 83,823 | 84,318 | –495 | –0.6 | |
Goodwill and other intangible assets |
| 86,218 | 90,652 | –4,434 | –4.9 |
Tax receivables |
| 268 | 230 | 38 | 16.5 |
Deferred tax assets |
| 9,187 | 8,302 | 885 | 10.7 |
Accrued receivables and prepaid expenses |
| 60,366 | 45,325 | 15,041 | 33.2 |
Other assets |
| 27,988 | 22,269 | 5,719 | 25.7 |
Total assets |
| 12,599,366 | 12,631,061 | –31,695 | –0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
in CHF 1,000 | Note | 30.06.2023 | 31.12.2022 | Variance | Variance |
|---|---|---|---|---|---|
|
|
|
| absolute | in % |
Due to banks |
| 355,350 | 178,776 | 176,574 | 98.8 |
Due to customers – savings and deposits |
| 462,065 | 503,322 | –41,257 | –8.2 |
Due to customers – other liabilities |
| 10,146,257 | 10,330,340 | –184,083 | –1.8 |
Derivative financial instruments |
| 90,022 | 89,546 | 476 | 0.5 |
Medium-term notes |
| 52,408 | 41,180 | 11,228 | 27.3 |
Debentures issued | 255,055 | 255,081 | –26 | –0.0 | |
Tax liabilities |
| 7,152 | 5,783 | 1,369 | 23.7 |
Deferred tax liabilities |
| 1,266 | 1,301 | –35 | –2.7 |
Accrued liabilities and deferred items |
| 52,459 | 45,878 | 6,581 | 14.3 |
Other liabilities | 76,034 | 75,707 | 327 | 0.4 | |
Provisions |
| 2,423 | 2,022 | 401 | 19.8 |
Total liabilities |
| 11,500,491 | 11,528,936 | –28,445 | –0.2 |
Share capital | 66,154 | 66,154 | 0 | 0.0 | |
Less: treasury shares | –49,963 | –53,220 | 3,257 | 6.1 | |
Capital reserves |
| 22,949 | 23,305 | –356 | –1.5 |
Retained earnings |
| 1,138,505 | 1,143,724 | –5,219 | –0.5 |
Actuarial gains/losses from defined-benefit |
| –30,241 | –25,797 | –4,444 | –17.2 |
Unrealised gains/losses on FVTOCI financial instruments |
| –19,016 | –24,757 | 5,741 | 23.2 |
Foreign-currency translation differences |
| –29,513 | –27,284 | –2,229 | –8.2 |
Total shareholders’ equity |
| 1,098,875 | 1,102,125 | –3,250 | –0.3 |
Total liabilities and shareholders’ equity |
| 12,599,366 | 12,631,061 | –31,695 | –0.3 |